These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 12886249

  • 1. Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.
    Lobe I, Rigal-Huguet F, Vekhoff A, Desablens B, Bordessoule D, Mounier C, Ferrant A, Sanz M, Fey M, Chomienne C, Chevret S, Degos L, Fenaux P, European APL group experience.
    Leukemia; 2003 Aug; 17(8):1600-4. PubMed ID: 12886249
    [Abstract] [Full Text] [Related]

  • 2. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Aug; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 3. Secondary clonal cytogenetic abnormalities following successful treatment of acute promyelocytic leukemia.
    Batzios C, Hayes LA, He SZ, Quach H, McQuilten ZK, Wall M, Campbell LJ.
    Am J Hematol; 2009 Nov; 84(11):715-9. PubMed ID: 19806661
    [Abstract] [Full Text] [Related]

  • 4. Translocation (2;11)(q37;q23) in therapy-related myelodysplastic syndrome after treatment for acute promyelocytic leukemia.
    Snijder S, Mellink CH, van der Lelie H.
    Cancer Genet Cytogenet; 2008 Jan 15; 180(2):149-52. PubMed ID: 18206542
    [Abstract] [Full Text] [Related]

  • 5. Therapy-related myelodysplastic syndrome after eradication of acute promyelocytic leukemia: cytogenetic and molecular features.
    Au WY, Lam CC, Ma ES, Man C, Wan T, Kwong YL.
    Hum Pathol; 2001 Jan 15; 32(1):126-9. PubMed ID: 11172306
    [Abstract] [Full Text] [Related]

  • 6. Outcome of childhood acute promyelocytic leukemia with all-trans-retinoic acid and chemotherapy.
    de Botton S, Coiteux V, Chevret S, Rayon C, Vilmer E, Sanz M, de La Serna J, Philippe N, Baruchel A, Leverger G, Robert A, San Miguel J, Conde E, Sotto JJ, Bordessoule D, Fegueux N, Fey M, Parry A, Chomienne C, Degos L, Fenaux P.
    J Clin Oncol; 2004 Apr 15; 22(8):1404-12. PubMed ID: 15084614
    [Abstract] [Full Text] [Related]

  • 7. Additional cytogenetic changes do not influence the outcome of patients with newly diagnosed acute promyelocytic leukemia treated with an ATRA plus anthracyclin based protocol. A report of the Spanish group PETHEMA.
    Hernández JM, Martín G, Gutiérrez NC, Cervera J, Ferro MT, Calasanz MJ, Martínez-Climent JA, Luño E, Tormo M, Rayón C, Díaz-Mediavilla J, González M, González-San Miguel JD, Pérez-Equiza K, Rivas C, Esteve J, Alvarez Mdel C, Odriozola J, Ribera JM, Sanz MA, PETHA Cooperative Group, Spain.
    Haematologica; 2001 Aug 15; 86(8):807-13. PubMed ID: 11522536
    [Abstract] [Full Text] [Related]

  • 8. All-trans retinoic acid therapy in relapsed/refractory or newly diagnosed acute promyelocytic leukemia (APL) in Japan.
    Ohno R, Ohnishi K, Takeshita A, Tanimoto M, Murakami H, Kanamaru A, Asou N, Kobayashi T, Kuriyama K, Ohmoto E.
    Leukemia; 1994 Aug 15; 8 Suppl 3():S64-9. PubMed ID: 7808028
    [Abstract] [Full Text] [Related]

  • 9. [Long-term follow-up of treatment outcome and prognosis on 46 children with acute promyelocytic leukemia].
    Xu XJ, Shi SW, Tang YM, Song H, Yang SL, Wei J, Xu WQ, Pan BH, Chen YH, Zhao FY, Shen HQ, Qian BQ, Zhang LY, Ning BT.
    Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb 15; 9(1):28-33. PubMed ID: 17306073
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G, Ottaviani E, Testoni N, Visani G, Diverio D, D'Elia G, Mandelli F, Tura S.
    Haematologica; 1998 Nov 15; 83(11):985-8. PubMed ID: 9864917
    [Abstract] [Full Text] [Related]

  • 16. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA, Rose AB, Felice MS, Alfaro E, Delfino S, Cygler AM, Sackmann-Muriel F.
    Pediatr Hematol Oncol; 2000 Mar 15; 17(2):155-62. PubMed ID: 10734658
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Acute promyelocytic leukemia. New methods in diagnosis and treatment.
    Varghese L, Janckila A, Yam LT.
    J Ky Med Assoc; 1999 Feb 15; 97(2):61-5. PubMed ID: 10073058
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Results of APL 91 European trial combining ATRA and chemotherapy: presentation of APL 1993 trial.
    Fenaux P.
    Leukemia; 1994 Feb 15; 8 Suppl 3():S70-2. PubMed ID: 7808029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.